Quick Takeaways
- Seven Fleet Capital Management LP filed SCHEDULE 13G/A for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
- Disclosed ownership: 0.02%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"Seven Fleet Capital Management LP disclosed 0.02% ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Seven Fleet Master Fund LP | 0.02% | 48,898 | 0 | 48,898 | /s/ Dr. Brian Liu | Dr. Brian Liu, Managing Member of Seven Fleet Capital Management LP, its Investment Mgr and Seven Fleet Capital Management GP, LLC, its Gen'l Ptr | |
| Seven Fleet Capital Management LP | 0.02% | 48,898 | 0 | 48,898 | /s/ Dr. Brian Liu | Dr. Brian Liu , Managing Member of Seven Fleet Capital Management GP, LLC, its General Partner | |
| Seven Fleet Capital Management GP LLC | 0.02% | 48,898 | 0 | 48,898 | /s/ Dr. Brian Liu | Dr. Brian Liu, Managing Member | |
| Brian Liu | 0.02% | 48,898 | 0 | 48,898 | /s/ Dr. Brian Liu | Dr. Brian Liu |